• Something wrong with this record ?

Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response

Z. Jiraskova Zakostelska, M. Kraus, S. Coufal, P. Prochazkova, Z. Slavickova, T. Thon, T. Hrncir, J. Kreisinger, K. Kostovcikova, P. Kleinova, J. Lizrova Preiningerova, M. Pavelcova, V. Ticha, I. Kovarova, E. Kubala Havrdova, H....

. 2024 ; 15 (-) : 1475126. [pub] 20241216

Language English Country Switzerland

Document type Journal Article

The gut microbiota influences the reactivity of the immune system, and Parabacteroides distasonis has emerged as an anti-inflammatory commensal. Here, we investigated whether its lysate could prevent severe forms of neuroinflammation in experimental autoimmune encephalomyelitis (EAE) in mice and how this preventive strategy affects the gut microbiota and immune response. Lysate of anaerobically cultured P. distasonis (Pd lysate) was orally administered to C57BL/6 mice in four weekly doses. One week later, EAE was induced and disease severity was assessed three weeks after induction. Fecal microbiota changes in both vehicle- and Pd lysate-treated animals was analyzed by 16S V3-V4 amplicon sequencing and qPCR, antimicrobial peptide expression in the intestinal mucosa was measured by qPCR, and immune cell composition in the mesenteric and inguinal lymph nodes was measured by multicolor flow cytometry. Pd lysate significantly delayed the development of EAE and reduced its severity when administered prior to disease induction. EAE induction was the main factor in altering the gut microbiota, decreasing the abundance of lactobacilli and segmented filamentous bacteria. Pd lysate significantly increased the intestinal abundance of the genera Anaerostipes, Parabacteroides and Prevotella, and altered the expression of antimicrobial peptides in the intestinal mucosa. It significantly increased the frequency of regulatory T cells, induced an anti-inflammatory milieu in mesenteric lymph nodes, and reduced the activation of T cells at the priming site. Pd lysate prevents severe forms of EAE by triggering a T regulatory response and modulating T cell priming to autoantigens. Pd lysate could thus be a future modulator of neuroinflammation that increases the resistance to multiple sclerosis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003019
003      
CZ-PrNML
005      
20250206104017.0
007      
ta
008      
250121e20241216sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2024.1475126 $2 doi
035    __
$a (PubMed)39737164
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jiraskova Zakostelska, Zuzana $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
245    10
$a Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response / $c Z. Jiraskova Zakostelska, M. Kraus, S. Coufal, P. Prochazkova, Z. Slavickova, T. Thon, T. Hrncir, J. Kreisinger, K. Kostovcikova, P. Kleinova, J. Lizrova Preiningerova, M. Pavelcova, V. Ticha, I. Kovarova, E. Kubala Havrdova, H. Tlaskalova-Hogenova, M. Kverka
520    9_
$a The gut microbiota influences the reactivity of the immune system, and Parabacteroides distasonis has emerged as an anti-inflammatory commensal. Here, we investigated whether its lysate could prevent severe forms of neuroinflammation in experimental autoimmune encephalomyelitis (EAE) in mice and how this preventive strategy affects the gut microbiota and immune response. Lysate of anaerobically cultured P. distasonis (Pd lysate) was orally administered to C57BL/6 mice in four weekly doses. One week later, EAE was induced and disease severity was assessed three weeks after induction. Fecal microbiota changes in both vehicle- and Pd lysate-treated animals was analyzed by 16S V3-V4 amplicon sequencing and qPCR, antimicrobial peptide expression in the intestinal mucosa was measured by qPCR, and immune cell composition in the mesenteric and inguinal lymph nodes was measured by multicolor flow cytometry. Pd lysate significantly delayed the development of EAE and reduced its severity when administered prior to disease induction. EAE induction was the main factor in altering the gut microbiota, decreasing the abundance of lactobacilli and segmented filamentous bacteria. Pd lysate significantly increased the intestinal abundance of the genera Anaerostipes, Parabacteroides and Prevotella, and altered the expression of antimicrobial peptides in the intestinal mucosa. It significantly increased the frequency of regulatory T cells, induced an anti-inflammatory milieu in mesenteric lymph nodes, and reduced the activation of T cells at the priming site. Pd lysate prevents severe forms of EAE by triggering a T regulatory response and modulating T cell priming to autoantigens. Pd lysate could thus be a future modulator of neuroinflammation that increases the resistance to multiple sclerosis.
650    _2
$a zvířata $7 D000818
650    12
$a encefalomyelitida autoimunitní experimentální $x imunologie $x prevence a kontrola $7 D004681
650    12
$a střevní mikroflóra $x imunologie $7 D000069196
650    _2
$a myši $7 D051379
650    12
$a myši inbrední C57BL $7 D008810
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a Bacteroidetes $x imunologie $7 D041963
650    _2
$a T-lymfocyty $x imunologie $x metabolismus $7 D013601
650    _2
$a střevní sliznice $x imunologie $x mikrobiologie $x metabolismus $7 D007413
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kraus, Michal $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Coufal, Stepan $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Prochazkova, Petra $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Slavickova, Zaneta $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Thon, Tomas $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Hrncir, Tomas $u Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Novy Hradek, Czechia
700    1_
$a Kreisinger, Jakub $u Laboratory of Animal Evolutionary Biology, Department of Zoology, Faculty of Science, Charles University, Prague, Czechia
700    1_
$a Kostovcikova, Klara $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Kleinova, Pavlina $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
700    1_
$a Lizrova Preiningerova, Jana $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
700    1_
$a Pavelcova, Miluse $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
700    1_
$a Ticha, Veronika $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
700    1_
$a Kovarova, Ivana $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
700    1_
$a Kubala Havrdova, Eva $u Department of Neurology and Centre of Clinical Neuroscience, First Medical Faculty, Charles University and General Medical Hospital in Prague, Prague, Czechia
700    1_
$a Tlaskalova-Hogenova, Helena $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Kverka, Miloslav $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 15 (20241216), s. 1475126
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39737164 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104013 $b ABA008
999    __
$a ok $b bmc $g 2263045 $s 1239026
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1475126 $e 20241216 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...